Showing results (71-80 of 174) with videos related to
Sort By:
Pageof 18
European Child & Adolescent Psychiatry|June 15, 2024
Risk factors for PTSD symptoms following PICU admission for childhood septic shockGeorgina J Corbet Burcher, Lisa A O'Dea, Mehrengise K Cooper, et al.Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|April 23, 2015
Mental and physical well-being following admission to pediatric intensive careLorraine C Als, Maria D Picouto, Sau-Ming Hau, et al.Journal of Clinical Pathology|May 10, 2012
HER2/neu testing for anti-HER2-based therapies in patients with unresectable and/or metastatic gastric cancerCarlos Gómez-Martin, Elena Garralda, M José Echarri, et al.Frontiers in Immunology|November 7, 2025
Optimizing early-phase immunotherapy trials: the role of biomarker enrichment strategiesGreta Catani, Daniel Morchón-Araujo, Oriol Mirallas, et al.International Journal of Molecular Sciences|June 13, 2025
Emerging Immunotherapy Targets in Early Drug DevelopmentDaniel Morchón-Araujo, Greta Catani, Oriol Mirallas, et al.European Child & Adolescent Psychiatry|December 21, 2016
Stress hormones and posttraumatic stress symptoms following paediatric critical illness: an exploratory studyLorraine C Als, Maria D Picouto, Kieran J O'Donnell, et al.NPJ Precision Oncology|February 21, 2024
A whirl of radiomics-based biomarkers in cancer immunotherapy, why is large scale validation still lacking?Marta Ligero, Bente Gielen, Victor Navarro, et al.Journal for Immunotherapy of Cancer|January 20, 2024
Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumorsMarkus Joerger, Emiliano Calvo, Heinz Laubli, et al.The Oncologist|August 2, 2023
A Phase I Dose-Escalation Study of LY3405105, a Covalent Inhibitor of Cyclin-Dependent Kinase 7, Administered to Patients With Advanced Solid TumorsElena Garralda, Alison M Schram, Philippe L Bedard, et al.Journal for Immunotherapy of Cancer|January 12, 2025
Radiomics signature for dynamic monitoring of tumor inflamed microenvironment and immunotherapy response predictionKinga Bernatowicz, Ramon Amat, Olivia Prior, et al.Pageof 18